Summary & Overview
HCPCS M1358: Persistent Suicidal Ideation or Behavior on Follow-Up
HCPCS Level II code M1358 documents patients who did not experience a reduction in suicidal ideation and/or behavior on follow-up assessment within 120 days of the index assessment. The code captures an important clinical outcome used in behavioral health quality measurement and care monitoring. Nationally, tracking persistence of suicidal ideation is critical for population safety monitoring, care coordination, and quality reporting across outpatient mental health services.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, its relevance to behavioral health follow-up and quality measurement, typical care settings where it is used, and what to expect in payer coverage considerations. The publication also summarizes common modifiers and notes where additional data are not available.
This material provides clinical and administrative context for clinicians, coding professionals, and policy analysts seeking to understand how persistence of suicidal ideation is recorded in claims and why that matters for monitoring outcomes and aligning care pathways across major payers.
Billing Code Overview
HCPCS Level II code M1358 indicates patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of the index assessment. This code represents a clinical follow-up outcome measure focused on persistent suicidal thoughts or behaviors after an initial evaluation.
-
Service type: Follow-up outcome assessment for persistent suicidal ideation and/or behavior
-
Typical site of service: Behavioral health outpatient settings, clinical follow-up visits, and other ambulatory mental health care environments
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient presents to an outpatient behavioral health clinic after an initial comprehensive suicide risk assessment documented active suicidal ideation with a plan. The index assessment is performed by a licensed mental health clinician and communicated to the patient's primary care provider and crisis team. The patient is engaged in a safety plan, start of medication management by a psychiatrist, and scheduled follow-up at 30, 60, and 90 days. At the 120-day follow-up assessment the clinician documents that suicidal ideation and/or behaviors have not decreased compared with the index assessment. The clinical workflow includes: initial risk assessment and documentation, coordination of care with psychiatry and crisis services, ongoing psychotherapy or case management, timely follow-up assessment within the 120-day window, and documentation of unchanged or worsening suicide-related symptoms to support billing under M1358.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or intensity of assessment and coordination substantially exceeds typical for a follow-up suicide risk evaluation. |
23 |